Publicaciones en colaboración con investigadores/as de Hospital Universitario Virgen del Rocío (20)

2024

  1. Heteroatom-tagged proteomics of lung cancer and chronic obstructive pulmonary disease human serum reveal alterations in selenoproteins

    Microchemical Journal, Vol. 199

2023

  1. A novel biocompatible polymer derived from D-mannitol used as a vector in the field of genetic engineering of eukaryotic cells

    Colloids and Surfaces B: Biointerfaces, Vol. 224

  2. Metallomic Signatures of Lung Cancer and Chronic Obstructive Pulmonary Disease

    International Journal of Molecular Sciences, Vol. 24, Núm. 18

  3. Untargeted Metabolomic Study of Lung Cancer Patients after Surgery with Curative Intent

    Journal of Proteome Research, Vol. 22, Núm. 11, pp. 3499-3507

2022

  1. Fluorescent Calixarene-Schiff as a Nanovehicle with Biomedical Purposes

    Chemosensors, Vol. 10, Núm. 7

  2. Single -and Multi-Walled Carbon Nanotubes as Nanocarriers for the Delivery of 7-Hydroxyflavone

    Pharmaceutics, Vol. 14, Núm. 12

2021

  1. Metallo-liposomes derived from the [ru(Bpy)3]2+ complex as nanocarriers of therapeutic agents

    Chemosensors, Vol. 9, Núm. 5

  2. Multivalent calixarene-based liposomes as platforms for gene and drug delivery

    Pharmaceutics, Vol. 13, Núm. 8

  3. Properties of polyplexes formed between a cationic polymer derived from l-arabinitol and nucleic acids

    New Journal of Chemistry, Vol. 45, Núm. 22, pp. 10098-10108

2020

  1. Metallo-liposomes of ruthenium used as promising vectors of genetic material

    Pharmaceutics, Vol. 12, Núm. 5

  2. Self-aggregation in aqueous solution of amphiphilic cationic calix[4]arenes. Potential use as vectors and nanocarriers

    Journal of Molecular Liquids, Vol. 304

2019

  1. Preparation and characterization of metallomicelles of Ru(II). Cytotoxic activity and use as vector

    Colloids and Surfaces B: Biointerfaces, Vol. 175, pp. 116-125

2017

  1. P-Sulfocalix[6]arene as Nanocarrier for Controlled Delivery of Doxorubicin

    Chemistry - An Asian Journal, Vol. 12, Núm. 6, pp. 679-689

2015

  1. Deciphering metabolic abnormalities associated with Alzheimer's disease in the APP/PS1 mouse model using integrated metabolomic approaches

    Biochimie, Vol. 110, pp. 119-128

  2. Metabolomic investigation of systemic manifestations associated with Alzheimer's disease in the APP/PS1 transgenic mouse model

    Molecular BioSystems, Vol. 11, Núm. 9, pp. 2429-2440

  3. Metabolomic research on the role of interleukin-4 in Alzheimer’s disease

    Metabolomics, Vol. 11, Núm. 5, pp. 1175-1183

  4. Metabolomic screening of regional brain alterations in the APP/PS1 transgenic model of Alzheimer's disease by direct infusion mass spectrometry

    Journal of Pharmaceutical and Biomedical Analysis, Vol. 102, pp. 425-435

  5. Metabolomics reveals significant impairments in the immune system of the APP/PS1 transgenic mice of Alzheimer's disease

    Electrophoresis, Vol. 36, Núm. 4, pp. 577-587

2014

  1. Region-specific metabolic alterations in the brain of the APP/PS1 transgenic mice of Alzheimer's disease

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1842, Núm. 12, pp. 2395-2402

2007

  1. Measurement of urine pH for epidemiological studies on bladder cancer

    European Journal of Epidemiology, Vol. 22, Núm. 2, pp. 91-98